CyberArk to Present at Upcoming Investor Conferences

NEWTON, Mass. & PETACH TIKVA, Israel--(BUSINESS WIRE)-- CyberArk (NASDAQ: CYBR), the global leader in privileged access security, today announced that it will present at the following investor conferences:

Oppenheimer 21st Annual Technology, Internet & Communications ConferenceBostonWednesday, August 8, 20181:45 p.m. ET

KeyBanc Capital Markets 20th Annual Technology Leadership ForumVail, Colo.Monday, August 13, 20182:30 p.m. MT

The presentations will be webcast live, and an archive of the presentations will be available for a limited time under the “Events & Presentations” section on the company’s investor relations website (http://investors.cyberark.com/).

About CyberArkCyberArk (NASDAQ: CYBR) is the global leader in privileged access security, a critical layer of IT security to protect data, infrastructure and assets across the enterprise, in the cloud and throughout the DevOps pipeline. CyberArk delivers the industry’s most complete solution to reduce risk created by privileged credentials and secrets. The company is trusted by the world’s leading organizations, including more than 50 percent of the Fortune 100, to protect against external attackers and malicious insiders. A global company, CyberArk is headquartered in Petach Tikva, Israel, with U.S. headquarters located in Newton, Mass. The company also has offices throughout the Americas, EMEA, Asia Pacific and Japan. To learn more about CyberArk, visit www.cyberark.com, read the CyberArk blogs or follow on Twitter via @CyberArk, LinkedIn or Facebook.

Copyright © 2018 CyberArk Software. All Rights Reserved. All other brand names, product names, or trademarks belong to their respective holders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180730005378/en/

Investor Contact:
CyberArk
Erica Smith, +1 617-558-2132
[email protected]
or
Media Contact:
CyberArk
Liz Campbell, +1 617-558-2191
[email protected]

Source: CyberArk

You May Also Be Interested In

• FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
• LTC Price Outlook Shifts as Clearstream Adds Litecoin to Custody and Pepeto Presale Pulls in $10.4 Million
• Best Crypto to Buy in July 2026: Pepeto Presale Beats ETH and ADA on Return Math